-
1
-
-
2342468034
-
Meta-analysis of large randomized controlled trials to evaluate the impact of statins on cardiovascular outcomes
-
Cheung B.M., Lauder I.J., Lau C.P., Kumana C.R. Meta-analysis of large randomized controlled trials to evaluate the impact of statins on cardiovascular outcomes. Br J Clin Pharmacol 2004, 57(5):640-651.
-
(2004)
Br J Clin Pharmacol
, vol.57
, Issue.5
, pp. 640-651
-
-
Cheung, B.M.1
Lauder, I.J.2
Lau, C.P.3
Kumana, C.R.4
-
2
-
-
70350451960
-
Genetic determinants of response to statins
-
Peters B.J., Klungel O.H., de Boer A., Maitland-van der Zee A.H. Genetic determinants of response to statins. Expert Rev Cardiovasc Ther 2009, 7(8):977-983.
-
(2009)
Expert Rev Cardiovasc Ther
, vol.7
, Issue.8
, pp. 977-983
-
-
Peters, B.J.1
Klungel, O.H.2
de Boer, A.3
Maitland-van der Zee, A.H.4
-
3
-
-
58849165389
-
Interaction between the Gly460Trp alpha-adducin gene variant and diuretics on the risk of myocardial infarction
-
van Wieren-de Wijer D.B., Maitland-van der Zee A.H., de Boer A., et al. Interaction between the Gly460Trp alpha-adducin gene variant and diuretics on the risk of myocardial infarction. J Hypertens 2009, 27(1):61-68.
-
(2009)
J Hypertens
, vol.27
, Issue.1
, pp. 61-68
-
-
van Wieren-de Wijer, D.B.1
Maitland-van der Zee, A.H.2
de Boer, A.3
-
4
-
-
77955631252
-
Pharmacogenetic interactions between ABCB1 and SLCO1B1 tagging SNPs and the effectiveness of statins in the prevention of myocardial infarction
-
Peters B.J.M., Rodin A.S., Klungel O.H., et al. Pharmacogenetic interactions between ABCB1 and SLCO1B1 tagging SNPs and the effectiveness of statins in the prevention of myocardial infarction. Pharmacogenomics 2010, 11(8):1065-1076.
-
(2010)
Pharmacogenomics
, vol.11
, Issue.8
, pp. 1065-1076
-
-
Peters, B.J.M.1
Rodin, A.S.2
Klungel, O.H.3
-
5
-
-
63049130363
-
Recruitment of participants through community pharmacies for a pharmacogenetic study of antihypertensive drug treatment
-
van Wieren-de Wijer D.B., Maitland-van der Zee A.H., de Boer A., et al. Recruitment of participants through community pharmacies for a pharmacogenetic study of antihypertensive drug treatment. Pharm World Sci 2009, 31(2):158-164.
-
(2009)
Pharm World Sci
, vol.31
, Issue.2
, pp. 158-164
-
-
van Wieren-de Wijer, D.B.1
Maitland-van der Zee, A.H.2
de Boer, A.3
-
6
-
-
35348983887
-
A second generation human haplotype map of over 3.1 million SNPs
-
Frazer K.A., Ballinger D.G., Cox D.R., et al. A second generation human haplotype map of over 3.1 million SNPs. Nature 2007, 449(7164):851-861.
-
(2007)
Nature
, vol.449
, Issue.7164
, pp. 851-861
-
-
Frazer, K.A.1
Ballinger, D.G.2
Cox, D.R.3
-
7
-
-
34547590995
-
QuickSNP: an automated web server for selection of tagSNPs
-
Web Server issue
-
Grover D., Woodfield A.S., Verma R., et al. QuickSNP: an automated web server for selection of tagSNPs. Nucleic Acids Res 2007, 35(Web Server issue):W115-W120.
-
(2007)
Nucleic Acids Res
, vol.35
-
-
Grover, D.1
Woodfield, A.S.2
Verma, R.3
-
8
-
-
0035173378
-
DbSNP: the NCBI database of genetic variation
-
Sherry S.T., Ward M.H., Kholodov M., et al. dbSNP: the NCBI database of genetic variation. Nucleic Acids Res 2001, 29(1):308-311.
-
(2001)
Nucleic Acids Res
, vol.29
, Issue.1
, pp. 308-311
-
-
Sherry, S.T.1
Ward, M.H.2
Kholodov, M.3
-
9
-
-
0028237283
-
The risk of myocardial infarction associated with the combined use of estrogens and progestins in postmenopausal women
-
Psaty B.M., Heckbert S.R., Atkins D., et al. The risk of myocardial infarction associated with the combined use of estrogens and progestins in postmenopausal women. Arch Intern Med 1994, 154(12):1333-1339.
-
(1994)
Arch Intern Med
, vol.154
, Issue.12
, pp. 1333-1339
-
-
Psaty, B.M.1
Heckbert, S.R.2
Atkins, D.3
-
10
-
-
0029161079
-
The risk of myocardial infarction associated with antihypertensive drug therapies
-
Psaty B.M., Heckbert S.R., Koepsell T.D., et al. The risk of myocardial infarction associated with antihypertensive drug therapies. JAMA 1995, 274(8):620-625.
-
(1995)
JAMA
, vol.274
, Issue.8
, pp. 620-625
-
-
Psaty, B.M.1
Heckbert, S.R.2
Koepsell, T.D.3
-
11
-
-
0042424602
-
Statistical significance for genomewide studies
-
Storey J.D., Tibshirani R. Statistical significance for genomewide studies. Proc Natl Acad Sci USA 2003, 100(16):9440-9445.
-
(2003)
Proc Natl Acad Sci USA
, vol.100
, Issue.16
, pp. 9440-9445
-
-
Storey, J.D.1
Tibshirani, R.2
-
12
-
-
77950458892
-
Influence of SCARB1 polymorphisms on serum lipids of hypercholesterolemic individuals treated with atorvastatin
-
Cerda A., Genvigir F.D., Arazi S.S., et al. Influence of SCARB1 polymorphisms on serum lipids of hypercholesterolemic individuals treated with atorvastatin. Clin Chim Acta 2010, 411(9-10):631-637.
-
(2010)
Clin Chim Acta
, vol.411
, Issue.9-10
, pp. 631-637
-
-
Cerda, A.1
Genvigir, F.D.2
Arazi, S.S.3
-
13
-
-
0037603589
-
Mutations in PCSK9 cause autosomal dominant hypercholesterolemia
-
Abifadel M., Varret M., Rabes J.P., et al. Mutations in PCSK9 cause autosomal dominant hypercholesterolemia. Nat Genet 2003, 34(2):154-156.
-
(2003)
Nat Genet
, vol.34
, Issue.2
, pp. 154-156
-
-
Abifadel, M.1
Varret, M.2
Rabes, J.P.3
-
14
-
-
33846679386
-
Molecular biology of PCSK9: its role in LDL metabolism
-
Horton J.D., Cohen J.C., Hobbs H.H. Molecular biology of PCSK9: its role in LDL metabolism. Trends Biochem Sci 2007, 32(2):71-77.
-
(2007)
Trends Biochem Sci
, vol.32
, Issue.2
, pp. 71-77
-
-
Horton, J.D.1
Cohen, J.C.2
Hobbs, H.H.3
-
15
-
-
33645103550
-
Sequence variations in PCSK9, low LDL, and protection against coronary heart disease
-
Cohen J.C., Boerwinkle E., Mosley T.H., Hobbs H.H. Sequence variations in PCSK9, low LDL, and protection against coronary heart disease. N Engl J Med 2006, 354(12):1264-1272.
-
(2006)
N Engl J Med
, vol.354
, Issue.12
, pp. 1264-1272
-
-
Cohen, J.C.1
Boerwinkle, E.2
Mosley, T.H.3
Hobbs, H.H.4
-
16
-
-
33748601835
-
The E670G SNP in the PCSK9 gene is associated with polygenic hypercholesterolemia in men but not in women
-
Evans D., Beil F.U. The E670G SNP in the PCSK9 gene is associated with polygenic hypercholesterolemia in men but not in women. BMC Med Genet 2006, 7:66.
-
(2006)
BMC Med Genet
, vol.7
, pp. 66
-
-
Evans, D.1
Beil, F.U.2
-
17
-
-
59849087105
-
The PCSK9 gene E670G polymorphism affects low-density lipoprotein cholesterol levels but is not a risk factor for coronary artery disease in ethnic Chinese in Taiwan
-
Hsu L.A., Teng M.S., Ko Y.L., et al. The PCSK9 gene E670G polymorphism affects low-density lipoprotein cholesterol levels but is not a risk factor for coronary artery disease in ethnic Chinese in Taiwan. Clin Chem Lab Med 2009, 47(2):154-158.
-
(2009)
Clin Chem Lab Med
, vol.47
, Issue.2
, pp. 154-158
-
-
Hsu, L.A.1
Teng, M.S.2
Ko, Y.L.3
-
18
-
-
73449143804
-
Effects of PCSK9 variants on common carotid artery intima media thickness and relation to ApoE alleles
-
Norata G.D., Garlaschelli K., Grigore L., et al. Effects of PCSK9 variants on common carotid artery intima media thickness and relation to ApoE alleles. Atherosclerosis 2008, 208(1):177-182.
-
(2008)
Atherosclerosis
, vol.208
, Issue.1
, pp. 177-182
-
-
Norata, G.D.1
Garlaschelli, K.2
Grigore, L.3
-
19
-
-
18944392912
-
A common PCSK9 haplotype, encompassing the E670G coding single nucleotide polymorphism, is a novel genetic marker for plasma low-density lipoprotein cholesterol levels and severity of coronary atherosclerosis
-
Chen S.N., Ballantyne C.M., Gotto A.M., et al. A common PCSK9 haplotype, encompassing the E670G coding single nucleotide polymorphism, is a novel genetic marker for plasma low-density lipoprotein cholesterol levels and severity of coronary atherosclerosis. J Am Coll Cardiol 2005, 45(10):1611-1619.
-
(2005)
J Am Coll Cardiol
, vol.45
, Issue.10
, pp. 1611-1619
-
-
Chen, S.N.1
Ballantyne, C.M.2
Gotto, A.M.3
-
20
-
-
33344464808
-
A spectrum of PCSK9 alleles contributes to plasma levels of low-density lipoprotein cholesterol
-
Kotowski I.K., Pertsemlidis A., Luke A., et al. A spectrum of PCSK9 alleles contributes to plasma levels of low-density lipoprotein cholesterol. Am J Hum Genet 2006, 78(3):410-422.
-
(2006)
Am J Hum Genet
, vol.78
, Issue.3
, pp. 410-422
-
-
Kotowski, I.K.1
Pertsemlidis, A.2
Luke, A.3
-
21
-
-
49949100564
-
Genetic variation at the PCSK9 locus moderately lowers low-density lipoprotein cholesterol levels, but does not significantly lower vascular disease risk in an elderly population
-
Polisecki E., Peter I., Robertson M., et al. Genetic variation at the PCSK9 locus moderately lowers low-density lipoprotein cholesterol levels, but does not significantly lower vascular disease risk in an elderly population. Atherosclerosis 2008, 200(1):95-101.
-
(2008)
Atherosclerosis
, vol.200
, Issue.1
, pp. 95-101
-
-
Polisecki, E.1
Peter, I.2
Robertson, M.3
-
22
-
-
36849085368
-
The PCSK9 gene R46L variant is associated with lower plasma lipid levels and cardiovascular risk in healthy U.K. men
-
Scartezini M., Hubbart C., Whittall R.A., et al. The PCSK9 gene R46L variant is associated with lower plasma lipid levels and cardiovascular risk in healthy U.K. men. Clin Sci (Lond) 2007, 113(11):435-441.
-
(2007)
Clin Sci (Lond)
, vol.113
, Issue.11
, pp. 435-441
-
-
Scartezini, M.1
Hubbart, C.2
Whittall, R.A.3
-
23
-
-
33646443979
-
Missense mutations in the PCSK9 gene are associated with hypocholesterolemia and possibly increased response to statin therapy
-
Berge K.E., Ose L., Leren T.P. Missense mutations in the PCSK9 gene are associated with hypocholesterolemia and possibly increased response to statin therapy. Arterioscler Thromb Vasc Biol 2006, 26(5):1094-1100.
-
(2006)
Arterioscler Thromb Vasc Biol
, vol.26
, Issue.5
, pp. 1094-1100
-
-
Berge, K.E.1
Ose, L.2
Leren, T.P.3
-
24
-
-
33749025102
-
Genetic causes of familial hypercholesterolaemia in patients in the UK: relation to plasma lipid levels and coronary heart disease risk
-
Humphries S.E., Whittall R.A., Hubbart C.S., et al. Genetic causes of familial hypercholesterolaemia in patients in the UK: relation to plasma lipid levels and coronary heart disease risk. J Med Genet 2006, 43(12):943-949.
-
(2006)
J Med Genet
, vol.43
, Issue.12
, pp. 943-949
-
-
Humphries, S.E.1
Whittall, R.A.2
Hubbart, C.S.3
-
25
-
-
33644807009
-
Severe hypercholesterolemia in four British families with the D374Y mutation in the PCSK9 gene: long-term follow-up and treatment response
-
Naoumova R.P., Tosi I., Patel D., et al. Severe hypercholesterolemia in four British families with the D374Y mutation in the PCSK9 gene: long-term follow-up and treatment response. Arterioscler Thromb Vasc Biol 2005, 25(12):2654-2660.
-
(2005)
Arterioscler Thromb Vasc Biol
, vol.25
, Issue.12
, pp. 2654-2660
-
-
Naoumova, R.P.1
Tosi, I.2
Patel, D.3
-
26
-
-
69549111453
-
Comprehensive whole-genome and candidate gene analysis for response to statin therapy in the Treating to New Targets (TNT) cohort
-
Thompson J.F., Hyde C.L., Wood L.S., et al. Comprehensive whole-genome and candidate gene analysis for response to statin therapy in the Treating to New Targets (TNT) cohort. Circ Cardiovasc Genet 2009, 2(2):173-181.
-
(2009)
Circ Cardiovasc Genet
, vol.2
, Issue.2
, pp. 173-181
-
-
Thompson, J.F.1
Hyde, C.L.2
Wood, L.S.3
-
27
-
-
0242668381
-
Hepatic lipase: a marker for cardiovascular disease risk and response to therapy
-
Zambon A., Deeb S.S., Pauletto P., Crepaldi G., Brunzell J.D. Hepatic lipase: a marker for cardiovascular disease risk and response to therapy. Curr Opin Lipidol 2003, 14(2):179-189.
-
(2003)
Curr Opin Lipidol
, vol.14
, Issue.2
, pp. 179-189
-
-
Zambon, A.1
Deeb, S.S.2
Pauletto, P.3
Crepaldi, G.4
Brunzell, J.D.5
-
28
-
-
0032032592
-
Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study)
-
Jones P., Kafonek S., Laurora I., Hunninghake D. Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study). Am J Cardiol 1998, 81(5):582-587.
-
(1998)
Am J Cardiol
, vol.81
, Issue.5
, pp. 582-587
-
-
Jones, P.1
Kafonek, S.2
Laurora, I.3
Hunninghake, D.4
-
29
-
-
0036805674
-
Statins as anti-inflammatory agents
-
Weitz-Schmidt G. Statins as anti-inflammatory agents. Trends Pharmacol Sci 2002, 23(10):482-486.
-
(2002)
Trends Pharmacol Sci
, vol.23
, Issue.10
, pp. 482-486
-
-
Weitz-Schmidt, G.1
-
30
-
-
0031010532
-
Validation of pharmacy records in drug exposure assessment
-
Lau H.S., de Boer A., Beuning K.S., Porsius A. Validation of pharmacy records in drug exposure assessment. J Clin Epidemiol 1997, 50(5):619-625.
-
(1997)
J Clin Epidemiol
, vol.50
, Issue.5
, pp. 619-625
-
-
Lau, H.S.1
de Boer, A.2
Beuning, K.S.3
Porsius, A.4
-
31
-
-
69849094785
-
Identification of genetic variants associated with response to statin therapy
-
Mega J.L., Morrow D.A., Brown A., Cannon C.P., Sabatine M.S. Identification of genetic variants associated with response to statin therapy. Arterioscler Thromb Vasc Biol 2009, 29:1310-1315.
-
(2009)
Arterioscler Thromb Vasc Biol
, vol.29
, pp. 1310-1315
-
-
Mega, J.L.1
Morrow, D.A.2
Brown, A.3
Cannon, C.P.4
Sabatine, M.S.5
|